EUVIMEDEUVIMED entdecken
Open Access

The role of revision sinus surgery in the initiation of dupilumab therapy: A real‐world study of molecular and cellular features

Abigail Gaffar, Abdul Rahman Alenezi, Kathleen M Kelly, Heather M Kulaga, Hsin-Tzu Keng, Amy Smith, Andrew P Lane iD

International Forum of Allergy & Rhinology · 2024

DOI: 10.1002/alr.23401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2024. Verfasst von Abigail Gaffar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Sinusitis, Rhinitis, Nasal Polyps. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key points A persistent type 2 endotype signature exists in recalcitrant chronic rhinosinusitis with nasal polyps mucosa on dupilumab. Revision sinus surgery immediately prior to dupilumab reduces long‐term interleukin (IL)‐4/IL‐13 tissue mRNA. Pre‐dupilumab revision surgery is associated with reduced tissue eosinophils and GATA‐3+ cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedSinusitisRhinitisNasal PolypsInterleukin-13ReoperationHumansChronic DiseaseFemaleInterleukin-4MaleEosinophilsMiddle AgedGATA3 Transcription FactorAdultNasal MucosaParanasal Sinuses

Stichwörter der Autor:innen

IL‐13IL‐4chronic rhinosinusitis with nasal polyposisdupilumabsinus surgery

Substanzen

dupilumabAntibodies, Monoclonal, HumanizedInterleukin-13Interleukin-4GATA3 Transcription FactorGATA3 protein, humanIL4 protein, humanIL13 protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Department of Otolaryngology-Head & Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

ORCID-Profile: Andrew P Lane

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Gaffar, A., Alenezi, A. R., Kelly, K. M., Kulaga, H. M., Keng, H. T., Smith, A., & Lane, A. P. (2024). The role of revision sinus surgery in the initiation of dupilumab therapy: A real‐world study of molecular and cellular features. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23401

Vancouver

Gaffar A, Alenezi AR, Kelly KM, Kulaga HM, Keng HT, Smith A, et al. The role of revision sinus surgery in the initiation of dupilumab therapy: A real‐world study of molecular and cellular features. International Forum of Allergy & Rhinology. 2024. doi:10.1002/alr.23401

BibTeX
@article{Gaffar2024,
  author = {Gaffar, Abigail and Alenezi, Abdul Rahman and Kelly, Kathleen M and Kulaga, Heather M and Keng, Hsin-Tzu and Smith, Amy and Lane, Andrew P},
  title = {The role of revision sinus surgery in the initiation of dupilumab therapy: A real‐world study of molecular and cellular features},
  journal = {International Forum of Allergy & Rhinology},
  year = {2024},
  doi = {10.1002/alr.23401}
}
Kostenlos starten →